Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
35.08
+0.21 (0.60%)
At close: Nov 24, 2025, 4:00 PM EST
35.08
0.00 (0.00%)
After-hours: Nov 24, 2025, 4:15 PM EST

HRTS Holdings Information

HRTS is an equity ETF with a total of 45 individual holdings. The top holdings are Eli Lilly and Company stock at 10.80%, Roche Holding AG at 4.64%, AstraZeneca at 4.33%, UnitedHealth Group at 4.07%, and Gilead Sciences at 3.84%.

Total Holdings
25
Top 10 Percentage
44.63%
Asset Class
Equity
ETF Category
Health
Assets
50.36M
PE Ratio
22.90

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company10.80%5,210
2RHHBYRoche Holding AG4.64%48,754
3LON: AZNAstraZeneca PLC4.33%12,208
4UNHUnitedHealth Group Incorporated4.07%6,577
5GILDGilead Sciences, Inc.3.84%15,449
6ABTAbbott Laboratories3.79%15,393
7TMOThermo Fisher Scientific Inc.3.63%3,186
8BSXBoston Scientific Corporation3.27%17,053
9JNJJohnson & Johnson3.17%7,863
10ABBVAbbVie Inc.3.09%6,769
11MDTMedtronic plc3.05%15,434
12SWX: NOVNNovartis AG2.80%11,319
13DHRDanaher Corporation2.69%6,092
14VRTXVertex Pharmaceuticals Incorporated2.65%3,154
15CPH: NOVO.BNovo Nordisk A/S2.49%25,819
16MRKMerck & Co., Inc.2.45%12,963
17REGNRegeneron Pharmaceuticals, Inc.2.37%1,618
18AMGNAmgen Inc.2.16%3,239
19BBIOBridgeBio Pharma, Inc.1.98%15,436
20MCKMcKesson Corporation1.97%1,168
21RVMDRevolution Medicines, Inc.1.94%13,975
22CYTKCytokinetics, Incorporated1.89%14,950
23ARWRArrowhead Pharmaceuticals, Inc.1.82%24,089
24ALNYAlnylam Pharmaceuticals, Inc.1.79%2,019
25CRNXCrinetics Pharmaceuticals, Inc.1.71%20,493
Showing 25 of 45 holdings
Subscribe to see the full list
As of Nov 20, 2025